Bortezomib ameliorates acute allograft rejection after renal transplant by inhibiting Tfh cell proliferation and differentiation via miR-15b/IRF4 axis

Lei Liu(Henan Normal University), Guiwen Feng(First Affiliated Hospital of Zhengzhou University), Jinfeng Li(Hebei Medical University), Xianlei Yang(First Affiliated Hospital of Zhengzhou University), Yonghua Feng(First Affiliated Hospital of Zhengzhou University), Hongchang Xie(First Affiliated Hospital of Zhengzhou University), Junxiang Wang(Xi'an Honghui Hospital), Zhigang Wang(Chinese PLA General Hospital)
International Immunopharmacology
August 1, 2019
10.1016/j.intimp.2019.105758
Cited by 10

Related Papers

Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
|Clinical Cancer Research|2017|272
Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
|Journal of Medicinal Chemistry|2013|221
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
|Journal of Clinical Oncology|2009|218
Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS
|Cell|2019|207
Evolution of buffering in a genetic circuit controlling plant stem cell proliferation
|Nature Genetics|2019|194